AstraZeneca’s Movantik receives FDA approval to treat OIC

AstraZeneca has received approval from the US Food and Drug Administration (FDA) for its Movantik (naloxegol) tablets C-II to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news